In a study published in Signal Transduction and Targeted Therapy, the researchers used MIR2911, a plant microRNA enriched in honeysuckle, as a proof-of-concept example.
The company aims to complete the international development and validation of the test, as well as to obtain European regulatory approval and commercialize it as a service and a kit.
The same family of artificial intelligence that powers today's image generators is now being aimed at one of biology's ...
Interesting Engineering on MSN
99% pure lithium extraction became possible with US scientists’ new electrochemical method
Researchers in the United States have developed a new method to extract 99% pure ...
Adenosine deaminase 2 deficiency (DADA2) is an inborn error of immunity leading to systemic vasculitis, haematological manifestations, immune deficiency and/or autoimmunity. We report the case of a 26 ...
In the study of bacteria, a longstanding dogma has held that two molecular machines—RNA polymerase, which leads the way in transcribing DNA into RNA, and ribosomes, which bring up the rear translating ...
Tiny particles released by most human cells may be promising targets for diagnosis and treatment of an array of diseases from cancer to Alzheimer's, but scientists have struggled to see them and study ...
National security, unlocked. Each Thursday, host Mary Louise Kelly and a team of NPR correspondents discuss the biggest national security news of the week. With decades of reporting from battlefields ...
Lee J. Martin, Professor of Pathology at Johns Hopkins University School of Medicine, discusses neonatal encephalopathy and his recent research into neonatal brain injury ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results